HPS Pharmacies wish to give notice that Pfizer is continuing to experience a supply interruption for dantrolene capsules and vials as follows:
|Product||ARTG||Expected Return Date|
|Dantrium® 25mg Capsules||42975||End July 2020|
|Dantrium® 50mg Capsules||42976||End July 2020|
|Dantrium® 20mg Vial||14435||End June 2020|
An internationally registered brand of dantrolene 25mg capsules and dantrolene 20mg injection vials are available under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer on 1800 675 229 or your pharmacist at HPS Pharmacies.